Drugplain

GoodSense Eye Drops Advanced Relief Moisturizer .1 g/100mL

dextran, polyethylene glycol 400, povidone, tetrahydrozoline HCl · SOLUTION · Preferred PHarmaceuticals Inc.

No Recall History
Plain English

GoodSense Eye Drops Advanced Relief Moisturizer is a solution containing dextran, polyethylene glycol 400, povidone, tetrahydrozoline hcl at .1 g/100mL, taken ophthalmic. Manufactured by Preferred PHarmaceuticals Inc..

Key Facts

Brand Name
GoodSense Eye Drops Advanced Relief Moisturizer
Generic Name
dextran, polyethylene glycol 400, povidone, tetrahydrozoline HCl
NDC Code (Product)
68788-8635
Manufacturer
Preferred PHarmaceuticals Inc.
Strength
.1 g/100mL
Dosage Form
SOLUTION
Route
OPHTHALMIC
Marketing Status
Application #
M018
Drug Class
Plasma Volume Expander [EPC]
Marketing Start
04/16/2024

Recall History

No Recall History

Frequently Asked Questions

What is GoodSense Eye Drops Advanced Relief Moisturizer used for?

GoodSense Eye Drops Advanced Relief Moisturizer contains dextran, polyethylene glycol 400, povidone, tetrahydrozoline HCl. It is a solution taken ophthalmic. Consult your doctor for specific uses.

Is GoodSense Eye Drops Advanced Relief Moisturizer a controlled substance?

GoodSense Eye Drops Advanced Relief Moisturizer is not classified as a controlled substance by the DEA.

What is the generic name for GoodSense Eye Drops Advanced Relief Moisturizer?

The generic name for GoodSense Eye Drops Advanced Relief Moisturizer is dextran, polyethylene glycol 400, povidone, tetrahydrozoline HCl. There are no other listed brand versions of dextran, polyethylene glycol 400, povidone, tetrahydrozoline HCl.

What is the NDC code for GoodSense Eye Drops Advanced Relief Moisturizer .1 g/100mL?

The NDC (National Drug Code) for GoodSense Eye Drops Advanced Relief Moisturizer .1 g/100mL is 68788-8635, listed by Preferred PHarmaceuticals Inc..

Product NDC

68788-8635

Package NDC

68788-8635-1

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)